Therapeutic methods employing substituted piperidines which are CCR3 antagonists
M Grundl, H Dollinger, R Giovannini, C Hoenke… - US Patent …, 2014 - Google Patents
US8653075B2 - Therapeutic methods employing substituted piperidines which are CCR3
antagonists - Google Patents US8653075B2 - Therapeutic methods employing substituted …
antagonists - Google Patents US8653075B2 - Therapeutic methods employing substituted …
Intracellular kinase inhibitors
GA Flynn, SA Lee, M Faris, DW Brandt… - US Patent …, 2013 - Google Patents
US8604031B2 - Intracellular kinase inhibitors - Google Patents US8604031B2 - Intracellular
kinase inhibitors - Google Patents Intracellular kinase inhibitors Download PDF Info Publication …
kinase inhibitors - Google Patents Intracellular kinase inhibitors Download PDF Info Publication …
Pharmaceutical formulations comprising ccr3 antagonists
A Fetscher, JM Scher - US Patent 10,213,421, 2019 - Google Patents
US10213421B2 - Pharmaceutical formulations comprising CCR3 antagonists - Google
Patents US10213421B2 - Pharmaceutical formulations comprising CCR3 antagonists …
Patents US10213421B2 - Pharmaceutical formulations comprising CCR3 antagonists …
Co-crystals and salts of CCR3-inhibitors
M Frank, H Haeberle, M Henry, T Pachur… - US Patent …, 2014 - Google Patents
US8742115B2 - Co-crystals and salts of CCR3-inhibitors - Google Patents US8742115B2 -
Co-crystals and salts of CCR3-inhibitors - Google Patents Co-crystals and salts of CCR3-inhibitors …
Co-crystals and salts of CCR3-inhibitors - Google Patents Co-crystals and salts of CCR3-inhibitors …
Process for the manufacturing of CRR inhibitors
A Duran, R Schmid - US Patent 8,680,280, 2014 - Google Patents
US8680280B2 - Process for the manufacturing of CRR inhibitors - Google Patents
US8680280B2 - Process for the manufacturing of CRR inhibitors - Google Patents Process …
US8680280B2 - Process for the manufacturing of CRR inhibitors - Google Patents Process …
Co-crystals and salts of CCR3-inhibitors
M Frank, H Haeberle, M Henry, T Pachur… - US Patent …, 2016 - Google Patents
4,289,781 A 9/1981 Bengtsson et al. 6,433,165 B1 8/2002 Luly et al.*(HX), R2b 6,476,054
B1 1 1/2002 Caldwell et al. pharmaceutical compositions containing the same, and meth …
B1 1 1/2002 Caldwell et al. pharmaceutical compositions containing the same, and meth …
Substituted piperidines as CCR3 antagonists
M Grundl, H Dollinger, R Giovannini… - US Patent App. 14 …, 2015 - Google Patents
EP O468187 A2 1, 1992 JP 20O25O1052 A 1, 2002 JP 20025O1898 A 1, 2002 JP
2006137718 A 6, 2006 WO 2006083390 A2 8, 2006 WO 2006091671 A1 8, 2006 WO …
2006137718 A 6, 2006 WO 2006083390 A2 8, 2006 WO 2006091671 A1 8, 2006 WO …
Pharmaceutical formulations comprising CCR3 antagonists
A Fetscher, JM Scher - US Patent 11,612,596, 2023 - Google Patents
US11612596B2 - Pharmaceutical formulations comprising CCR3 antagonists - Google Patents
US11612596B2 - Pharmaceutical formulations comprising CCR3 antagonists - Google Patents …
US11612596B2 - Pharmaceutical formulations comprising CCR3 antagonists - Google Patents …
[HTML][HTML] Patent 2734578 Summary
RP GLADUE, BT KELLER, S OGAWA… - multiple sclerosis (Koch …, 2011 - ic.gc.ca
L'invention concerne des anticorps, notamment des anticorps humains, et leurs parties de
liaison à l'antigène qui se lient spécifiquement au récepteur CCR2, particulièrement le …
liaison à l'antigène qui se lient spécifiquement au récepteur CCR2, particulièrement le …
Methods of identifying and using modulators of fractalkine receptor
I Silos-Santiago - 2003 - Google Patents
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-
oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo …
oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo …